Compare
RetinalGenix Technologies Inc. vs ALR Technologies SG Ltd. vs Odyssey Health, Inc. vs Global Innovative Platforms Inc.
| Latest fiscal year | RetinalGenix Technologies Inc. RTGN | ALR Technologies SG Ltd. ALRTF | Odyssey Health, Inc. ODYY | Global Innovative Platforms Inc. GIPL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-07-31 | 2025-09-30 |
| Revenue | n/a | n/a | n/a | $0 |
| Revenue growth (YoY) | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a |
| Net income | -$2.43M | -$22.06M | -$1.74M | -$718.3K |
| EPS (Diluted) | -$0.13 | -$0.04 | -$0.02 | -$0.02 |
| Operating cash flow | -$558.4K | -$1.87M | -$347.4K | -$560.7K |
| Free cash flow | n/a | n/a | n/a | n/a |
| Cash & equivalents | n/a | n/a | n/a | n/a |
| Total assets | $21.0K | $47.4K | $49.7K | $199.3K |
| Total liabilities | $2.32M | $39.91M | n/a | $11.6K |
| Shareholders' equity | -$2.30M | -$39.86M | -$6.95M | $187.7K |
| Return on year-end equity | n/a | n/a | n/a | -382.7% |
| Shares outstanding | 18.75M | n/a | 96.71M | 44.48M |
Revenue, most recent five fiscal years
| Fiscal year | RetinalGenix Technologies Inc. | ALR Technologies SG Ltd. | Odyssey Health, Inc. | Global Innovative Platforms Inc. |
|---|---|---|---|---|
| Latest | n/a | $25.5K Ended 2023-12-31 | $0 Ended 2020-07-31 | $0 Ended 2025-09-30 |
| 1 year earlier | n/a | $2.4K Ended 2022-12-31 | $0 Ended 2019-07-31 | $0 Ended 2024-09-30 |
| 2 years earlier | n/a | $7.5K Ended 2021-12-31 | $0 Ended 2018-07-31 | $0 Ended 2023-09-30 |
| 3 years earlier | n/a | n/a | $0 Ended 2017-07-31 | $0 Ended 2022-09-30 |
| 4 years earlier | n/a | n/a | $37.5K Ended 2016-07-31 | $0 Ended 2021-09-30 |